Breast screens for trans women stirs debate

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 32 No 9
Volume 32
Issue 9

Breast screening habits for transsexual women shouldn't differ from those of biological women, according to a recent European study.

Breast screening habits for transsexual women shouldn't differ from those of biological women, according to a recent European study. However, a human sexuality expert disagrees, saying screening for transsexual women should depend on when the patient started estrogen therapy and not age alone.

The researchers found mammography and breast sonography were technically feasible in the 50 women who received sex-reassignment surgery. No gross anomalies were detected. In addition, 98% of the patients intended to come back for screening (EJR 2010;74:
508-513).

The study recommended a normal screening regimen for transsexual women. The mean age of study subjects was 43 ± 10.5 years.

Not everyone agrees with the study's conclusions, however.

Screening mammography for transsexual women should start at age 50, provided they have had five years of hormone therapy, said Dr. Jamie Feldman, an associate professor in the human sexuality program at the University of Minnesota.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.